🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To investigate the relative bioavailability of HSK7653(5mg) given as formul...
Status
Completed
Location
The First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Start Date
2022-06-15
Trial ID
NCT06003088
Treatments Being Tested
The purpose of this study is to compare the efficacy of once daily dosing w...
Status
Completed
Location
Multiple Locations
Start Date
2002-04
Trial ID
NCT00641979
Treatments Being Tested
The purpose of this study is to determine whether atazanavir powder combine...
Status
Completed
Location
Local Institution
Start Date
2010-10-13
Trial ID
NCT01099579
Treatments Being Tested
GW842166X is a selective non-cannabinoid CB2 receptor agonist, which is und...
Status
Withdrawn
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00536497
Treatments Being Tested
To evaluate patient acceptance of a new MiraLax dose formulation in childre...
Status
Completed
Location
Multiple Locations
Start Date
2006-03
Trial ID
NCT00319670
Treatments Being Tested
a study to investigate the pharmacokinetic characteristics and safety/toler...
Status
Unknown
Location
Gachon University Gil Medical Center
Start Date
2019-04-01
Trial ID
NCT03920579
Treatments Being Tested
This study involves 2 parts, Part A and Part B. The purpose of Part A is to...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2012-09
Trial ID
NCT01681186
Treatments Being Tested
The main aims of the study are to check for side effects from teduglutide. ...
Status
Completed
Location
University of Tsukuba Hospital
Start Date
2022-01-04
Trial ID
NCT05027308
Treatments Being Tested
Primary Objective: To evaluate for each influenza strain the non-inferiori...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00391391
ACTT-2 will evaluate the combination of baricitinib and remdesivir compared...
Status
Completed
Location
University of Alabama at Birmingham School of Medicine - Infectious Disease
Start Date
2020-05-08
Trial ID
NCT04401579
Treatments Being Tested